Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Novel agents for intractable itch.

C B Lynde1, J N Kraft, C W Lynde

  • 1Faculty of Medicine, University of Toronto, Toronto, ON, Canada.

Skin Therapy Letter
|March 22, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expert consensus on the systemic treatment of atopic dermatitis in special populations.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Treatment satisfaction, safety and effectiveness of adding methotrexate to adalimumab in patients with psoriasis responding suboptimally to adalimumab in a real-world setting.

The British journal of dermatology·2021
Same author

Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyond.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Alitretinoin for prurigo nodularis.

Clinical and experimental dermatology·2021
Same author

Topical treatment of psoriasis: questionnaire results on topical therapy as long-term continuous treatment and use on specific body sites.

The Journal of dermatological treatment·2020
Same author

Shifting the focus - the primary role of IL-23 in psoriasis and other inflammatory disorders.

Journal of the European Academy of Dermatology and Venereology : JEADV·2018
Same journal

Exosomes in Dermatology.

Skin therapy letter·2026
Same journal

Zasocitinib: New Frontier in Tyrosine Kinase 2 Inhibition.

Skin therapy letter·2026
Same journal

Erratum to: Deuruxolitinib for Alopecia Areata.

Skin therapy letter·2026
Same journal

Advances in the Management of Hyperhidrosis.

Skin therapy letter·2026
Same journal

Topical Ruxolitinib for the Treatment of Hidradenitis Suppurativa.

Skin therapy letter·2026
Same journal

Icotrokinra: A Promising Oral IL-23 Receptor Inhibitor for Moderate-to-Severe Plaque Psoriasis.

Skin therapy letter·2026
See all related articles

Intractable itch, or pruritus, management requires identifying the cause. Novel agents like opiate receptor antagonists, antidepressants, and antiepileptics offer new hope for symptomatic relief.

Area of Science:

  • Dermatology and Pharmacology
  • Exploration of novel antipruritic agents

Background:

  • Intractable itch (pruritus) is a debilitating symptom stemming from various underlying medical conditions.
  • Effective management hinges on accurate diagnosis of the pruritus's root cause.

Purpose of the Study:

  • To review emerging therapeutic strategies for intractable itch.
  • To explore the efficacy of non-traditional drugs as antipruritic agents.

Main Methods:

  • Literature review of studies on novel antipruritic medications.
  • Analysis of drug classes not typically used for cutaneous disorders.

Main Results:

  • Opiate receptor antagonists have demonstrated potential in managing pruritus.
  • Antidepressants and antiepileptics show promise as symptomatic treatments for intractable itch.

Related Experiment Videos

  • These agents offer alternative options when traditional therapies fail.

    • Conclusions:

    • Non-traditional pharmacological agents represent a significant advancement in pruritus management.
    • Further research into these novel antipruritic drugs is warranted.
    • Personalized treatment approaches targeting the underlying cause are crucial for managing intractable itch.